Harbour Antibodies competitors

Harbour Antibodies's competitors include Potenza Therapeutics, NovellusDx, UNUM Therapeutics and MedImmune
Add company...
Harbour Antibodies
Harbour Antibodies uses transgenic mouse technology for engineering mice to produce high affinity human antibodies.
Potenza Therapeutics
Potenza Therapeutics is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs that utilize the body’s own immune system to seek out, recognize and destroy tumors through a diversity of mechanisms that influence tumor immunity
NovellusDx
NovellusDx is dedicated to delivering the actionable intelligence that oncologists require to choose the right therapy for each patient. NovellusDx provides comprehensive, fully-automated, functional gene profiling of individual patient tumors including charting the full landscape of known and unknown mutations that drive the cancer’s progression.
UNUM Therapeutics
Cancer cell therapy company developing a platform to couple tumor-specific antibodies to the body’s own immune system.
MedImmune
MedImmune develops medicines for unmet medical needs worldwide.
Founding Date
Founding Date
2006
Founding Date
2014
Founding Date
2012
Founding Date
2014
Founding Date
1987
Type
Type
Private
Type
Private
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Cambridge, US HQ
Locations
Cambridge, US HQ
Locations
Jerusalem, IL HQ
Locations
Cambridge, US HQ
Locations
Gaithersburg, US HQ
Great Abington, GB
Mountain View, US
Employees
Employees
2100% increase
Employees
20
Employees
N/A
Employees
563% decrease
Employees
4,050
Twitter followers
Twitter followers
N/A
Twitter followers
50
Twitter followers
N/A
Twitter followers
687
Twitter followers
26.2 k

Funding

Latest funding round
Latest funding round
$ 3.2m (about 5 years ago)
Latest funding round
$ 30m (over 2 years ago)
Latest funding round
$ 6m (4 months ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 3.2m
Total funding raised
$ 30m
Total funding raised
$ 34.5m
Total funding raised
$ 178.3m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Potenza Therapeutics
HQ
Cambridge, US
Employees
20

Potenza Therapeutics is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs that utilize the body’s own immune system to seek out, recognize and destroy tumors through a diversity of mechanisms that influence tumor immunity

View company
NovellusDx
HQ
Jerusalem, IL

NovellusDx is dedicated to delivering the actionable intelligence that oncologists require to choose the right therapy for each patient. NovellusDx provides comprehensive, fully-automated, functional gene profiling of individual patient tumors including charting the full landscape of known and unknown mutations that drive the cancer’s progression.

View company
UNUM Therapeutics
HQ
Cambridge, US
Employees
56↓ 3% decrease

Cancer cell therapy company developing a platform to couple tumor-specific antibodies to the body’s own immune system.

View company
MedImmune
HQ
Gaithersburg, US
Employees
4,050

MedImmune develops medicines for unmet medical needs worldwide.

View company